Remove Assay Development Remove Molecular Biology Remove Small Molecule
article thumbnail

Turning science into business: AnĀ optimised alternative to antibodies

Drug Discovery World

AT : The major interest we see is in the targeted delivery of therapeutic molecules. We are working with partners to develop delivery vehicles for small molecule payloads as next-generation precision chemotherapy and supporting partners with targeted delivery and cell penetration for gene therapies.

Science 130
article thumbnail

AI At The Frontier: Empowering Early Career Professionals In Drug Discovery

Elrig

My role involved generating and characterizing complex proteins critical for biological assay development, hit discovery, and structural biology. Fascinated by the potential of AI in medical research, I transitioned to BenevolentAI in early 2023 as a Biology Project Leader.